Crypto
Bitcoin as an alternative reserve – MicroStrategy considers buying even more BTC
The company MicroStrategy recently invested in Bitcoin, purchasing 21,454 BTC. Moreover, now the company is indicating that it may increase its Bitcoin inventory in the future. MicroStrategy’s leadership said it was considering BTC and other crypto assets because it saw a weakening of the U.S. dollar. The company has recognized Bitcoin as a legitimate investment that can outperform cash.
Bitcoin is increasingly becoming an alternative store of value. Meanwhile, this applies not only to many private investors but also to institutional investors. A few weeks ago even a listed company from the USA dared to invest in Bitcoin.
The billion-dollar Business Intelligence software company MicroStrategy has announced that it will invest its cash reserves of $250 million in Bitcoin over the next 12 months. A few days after this announcement, the company has already put its plan into action.
If you want to read more about MicroStrategy investment in Bitcoin and why the company now believes that BTC has become a very good alternative reserve, download for free the Born2Invest mobile app. Find out the most important business news in the crypto sector and stay on top of the market with our companion app.
Bitcoin as an alternative reserve
MicroStrategy’s purchase of 21,454 BTC was a signal to other companies that Bitcoin could be used as a serious reserve. Moreover, now the company is indicating that it may increase its Bitcoin inventory in the future.
In a filing with the U.S. Securities and Exchange Commission on Friday, September 11th, the company stated that its Board of Directors has updated the company’s reserve policy. The new policy states that Bitcoin will now serve as the company’s primary reserve alongside cash, cash equivalents and short-term investments.
“As a result of this new policy, the company’s holdings of Bitcoin may increase beyond the $250 million investment announced by the Company on August 11, 2020,” the statement said.
US dollar makes alternatives more and more interesting
MicroStrategy may not make any promises, but after investing a quarter of a million dollars in Bitcoin just a month ago, it is clear that it is not questioning this decision – even in light of the recent downward movement in the price of Bitcoin and other cryptocurrencies.
Originally, MicroStrategy’s leadership said it was considering BTC and other crypto assets because it saw a weakening of the U.S. dollar in light of low Western interest rates and the impact of the U.S. stimulus measures to combat the COVID 19 pandemic. Days later, the purchase was announced.
“This investment reflects our belief that Bitcoin, as the world’s most widely used cryptocurrency, is a reliable store of value and an attractive asset with more long-term appreciation potential than cash,” said Michael Saylor, CEO of MicroStrategy, in August.
MicroStrategy has recognized Bitcoin as a legitimate investment that can outperform cash and has accordingly made Bitcoin the most important asset in its treasury reserve strategy.
MicroStrategy’s CEO envisioned the end of Bitcoin in 2013
Interestingly, Saylor’s announcement is an about-turn. In 2013, he predicted the death of BTC and tweeted: “The days of Bitcoin are numbered. It seems only a matter of time before it will suffer the same fate as online gambling.”
The price of Bitcoin at the time of MicroStrategy’s purchase last month was approximately 10 times higher than when Saylor tweeted this view in 2013. So that’s how wrong someone can be when predicting the future of Bitcoin. The crypto sector can surprise even the most experienced analyst.
__
(Featured image by ElvindPedersen via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Coin Kurier, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Biotech2 weeks ago
Brain Biotech Sells License Rights for 128 Million Euros to Royalty Pharma
-
Cannabis4 days ago
Cannabis and Psychedelics Consumption at Historic High, Study Shows
-
Crypto1 week ago
Binance Launches Pre-Market – Trade Cryptocurrencies Before Stock Market Debut
-
Cannabis2 days ago
Original Gangster Deluxe – New Medical Cannabis Strain from Canopy Growth Coming Soon to Polish Pharmacies